Tracy Esther Liu, MD
Physical Medicine & Rehabilitation · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Liu’s office at (650) 988-7588 to ask if they take your plan before you enroll.
California Medical Board record
Licence A36764 · Cancelled
Licence status: Cancelled · since 1981 · Chung-Shan Medical and Dental College.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 22 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 22 | None | 0% (0) | 0% | $289 |
| 2021 | 38 | None | 0% (0) | 0% | $439 |
| 2020 | 49 | None | 0% (0) | None | $857 |
| 2019 | 56 | None | 0% (0) | None | $1,214 |
| 2018 | 52 | None | 0% (0) | None | $1,607 |
| 2017 | 91 | None | 0% (0) | 31% | $10,160 |
| 2016 | 59 | None | 0% (0) | 29% | $10,405 |
| 2015 | 64 | None | 0% (0) | 34% | $12,038 |
| 2014 | 23 | None | 0% (0) | None | $7,592 |
| 2013 | 27 | None | 0% (0) | 44% | $11,108 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Losartan | 11 | $102 | $9 |
2019: 1 drug
| Alendronate | 16 | $77 | $5 |
2017: 1 drug
| Dexilant | 12 | $3,054 | $254 |
2016: 1 drug
| Alendronate | 11 | $134 | $12 |
2015: 1 drug
| Alendronate | 11 | $125 | $11 |
Money from drug and device companies
$68 in 2025
| 2025 | 1 | 1 | None | $68 |
| 2022 | 1 | 1 | None | $25 |
| 2021 | 1 | 1 | None | $23 |
| 2019 | 2 | 8 | None | $196 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | None | $68 | 1 payment
|
See the published payment
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-10 | None | $68 |
See earlier years (2022, 2021, 2019)
2022: $25
| TherapeuticsMD | Annovera | $25 | 1 payment
|
2021: $23
| TherapeuticsMD | Annovera | $23 | 1 payment
|
2019: $196
| TherapeuticsMD | Imvexxy | $129 | 7 payments
|
| Gilead Sciences | Vemlidy | $68 | 1 payment
|
Professional record
- NPI
- 1811176175
- Licence
- CA A36764California A36764: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- 2485 Hospital Dr., Suite 260, Mountain View, CA, 94040
- NPI first listed
- 2007-11-02
- NPI last updated
- 2017-01-04
This is when the NPI record was last certified, not a medical board exam.